Scientific article

Komorbiditaten bei Psoriasis vulgaris

Other titleCo-morbidities in psoriasis vulgaris
Published inDer Hautarzt, vol. 60, no. 2, p. 116-121
Publication date2009

Epidemiologic data document not only a higher prevalence of joint involvement among psoriasis patients than previously thought, but also an association with numerous other diseases, including depression, smoking, alcoholism, Crohn's disease, and metabolic syndrome. The resulting increased cardiovascular mortality is of particular clinical importance, and its pathogenetic link as a complication of the psoriatic inflammation is well recognized. Thus, we need to re-invent the management of psoriasis: Dermatologists are not only the sentinel regarding the early diagnosis of psoriatic arthritis, but also of metabolic complications such as dyslipidemia or diabetes. Moreover, they need to keep in mind interactions between (systemic) anti-psoriatic drugs and the co-medication of their patients as well as possible consequences of these co-medications on the course of psoriasis. To successfully accomplish this mission, a comprehensive management concept and ground-breaking research are urgently needed.

  • Cardiovascular Diseases/*epidemiology
  • Comorbidity
  • Depression/*epidemiology
  • Humans
  • Incidence
  • Metabolic Syndrome X/*epidemiology
  • Psoriasis/*epidemiology
  • *Risk Assessment
  • Risk Factors
  • Smoking/*epidemiology
  • Stress, Psychological/*epidemiology
Affiliation Not a UNIGE publication
Citation (ISO format)
BOEHNCKE, Wolf-Henning, BUERGER, C., BOEHNCKE, Sandra. Komorbiditaten bei Psoriasis vulgaris. In: Der Hautarzt, 2009, vol. 60, n° 2, p. 116–121. doi: 10.1007/s00105-008-1663-3
Main files (1)
ISSN of the journal0017-8470

Technical informations

Creation09/20/2013 4:49:00 PM
First validation09/20/2013 4:49:00 PM
Update time03/14/2023 8:26:17 PM
Status update03/14/2023 8:26:17 PM
Last indexation02/12/2024 8:34:15 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack